valine and incb-018424

valine has been researched along with incb-018424 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brower, V1
Al-Ali, HK; Gopalakrishna, P; Hubert, K; Koehler, A; Lange, T; Monecke, A; Niederwieser, D; Siebolts, U; Wickenhauser, C1
Garcia, KC; Hafer, M; Hitchcock, IS; Hubbard, SR; Kurre, R; Löchte, S; Moraga, I; Piehler, J; Poojari, C; Pulgar Prieto, KD; Richter, CP; Sharma, V; Stanly, TA; Tucker, JA; Vattulainen, I; Vuorio, J; Wilmes, S; Winkelmann, H1

Other Studies

3 other study(ies) available for valine and incb-018424

ArticleYear
Myeloproliferative cancers: treatment prospects for rare diseases.
    Journal of the National Cancer Institute, 2012, Nov-21, Volume: 104, Issue:22

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow Transplantation; Clinical Trials as Topic; Humans; Interferon-alpha; Janus Kinase 2; Leukemia, Myeloid; Mutation; Nitriles; Phenylalanine; Polyethylene Glycols; Pyrazoles; Pyrimidines; Rare Diseases; Recombinant Proteins; Valine

2012
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib.
    Annals of hematology, 2015, Volume: 94, Issue:11

    Topics: Amino Acid Substitution; Humans; Janus Kinase 2; Male; Middle Aged; Nitriles; Phenylalanine; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Remission Induction; Valine

2015
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.
    Science (New York, N.Y.), 2020, 02-07, Volume: 367, Issue:6478

    Topics: Amino Acid Substitution; Carcinogenesis; Cell Membrane; HeLa Cells; Humans; Janus Kinase 2; Ligands; Microscopy, Fluorescence; Models, Molecular; Mutation; Nitriles; Phenylalanine; Protein Multimerization; Pyrazoles; Pyrimidines; Receptors, Erythropoietin; Receptors, Somatotropin; Receptors, Thrombopoietin; Signal Transduction; Single Molecule Imaging; Valine

2020